Skip to main content

Peer Review reports

From: Dolutegravir plus lamivudine versus efavirenz plus tenofovir disoproxil fumarate and lamivudine in antiretroviral-naive adults with HIV-1 infection

Original Submission
30 Sep 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
15 Oct 2021 Reviewed Reviewer Report
6 Nov 2021 Reviewed Reviewer Report - Amedeo Capetti
29 Nov 2021 Author responded Author comments - Zhongsi Hong
Resubmission - Version 3
29 Nov 2021 Submitted Manuscript version 3
7 Dec 2021 Author responded Author comments - Zhongsi Hong
Resubmission - Version 4
7 Dec 2021 Submitted Manuscript version 4
Publishing
17 Dec 2021 Editorially accepted
4 Jan 2022 Article published 10.1186/s12879-021-06991-y

You can find further information about peer review here.

Back to article page